SPS
DTIL icon

Susquehanna Portfolio Strategies’s Precision BioSciences DTIL Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Buy
+24,409
New +$172K ﹤0.01% 799

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Susquehanna Portfolio Strategies's DTIL Position: Q2 2026 in Review

Susquehanna Portfolio Strategies opened a new position in Precision BioSciences (DTIL) in Q2 2026: 24,409 shares worth $192K. The stake represents ﹤0.01% of the portfolio and ranks #799 among its holdings.

95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Susquehanna Portfolio Strategies held 24,409 shares of Precision BioSciences worth $192K as of Q2 2026.
  • Precision BioSciences was a new Susquehanna Portfolio Strategies position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #799 holding.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.